192 related articles for article (PubMed ID: 19118122)
1. Modulation of excitatory synaptic transmission by Delta 9-tetrahydrocannabinol switches from agonist to antagonist depending on firing rate.
Roloff AM; Thayer SA
Mol Pharmacol; 2009 Apr; 75(4):892-900. PubMed ID: 19118122
[TBL] [Abstract][Full Text] [Related]
2. Delta9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture.
Shen M; Thayer SA
Mol Pharmacol; 1999 Jan; 55(1):8-13. PubMed ID: 9882692
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids depress excitatory neurotransmission between the subthalamic nucleus and the globus pallidus.
Freiman I; Szabo B
Neuroscience; 2005; 133(1):305-13. PubMed ID: 15893652
[TBL] [Abstract][Full Text] [Related]
4. Endocannabinoids suppress excitatory synaptic transmission to dorsal raphe serotonin neurons through the activation of presynaptic CB1 receptors.
Haj-Dahmane S; Shen RY
J Pharmacol Exp Ther; 2009 Oct; 331(1):186-96. PubMed ID: 19592666
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata.
Szabo B; Wallmichrath I; Mathonia P; Pfreundtner C
Neuroscience; 2000; 97(1):89-97. PubMed ID: 10771342
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptor modulation of synapses received by cerebellar Purkinje cells.
Takahashi KA; Linden DJ
J Neurophysiol; 2000 Mar; 83(3):1167-80. PubMed ID: 10712447
[TBL] [Abstract][Full Text] [Related]
7. Delta 9-tetrahydrocannabinol antagonizes endocannabinoid modulation of synaptic transmission between hippocampal neurons in culture.
Kelley BG; Thayer SA
Neuropharmacology; 2004 Apr; 46(5):709-15. PubMed ID: 14996548
[TBL] [Abstract][Full Text] [Related]
8. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors.
Melis M; Pistis M; Perra S; Muntoni AL; Pillolla G; Gessa GL
J Neurosci; 2004 Jan; 24(1):53-62. PubMed ID: 14715937
[TBL] [Abstract][Full Text] [Related]
9. Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors.
Hoffman AF; Laaris N; Kawamura M; Masino SA; Lupica CR
J Neurosci; 2010 Jan; 30(2):545-55. PubMed ID: 20071517
[TBL] [Abstract][Full Text] [Related]
10. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
McMahon LR
J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255
[TBL] [Abstract][Full Text] [Related]
11. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum.
Gerdeman G; Lovinger DM
J Neurophysiol; 2001 Jan; 85(1):468-71. PubMed ID: 11152748
[TBL] [Abstract][Full Text] [Related]
12. Effect of chronic administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice.
Sim-Selley LJ; Martin BR
J Pharmacol Exp Ther; 2002 Oct; 303(1):36-44. PubMed ID: 12235230
[TBL] [Abstract][Full Text] [Related]
13. Effects of exogenous and endogenous cannabinoids on GABAergic neurotransmission between the caudate-putamen and the globus pallidus in the mouse.
Engler B; Freiman I; Urbanski M; Szabo B
J Pharmacol Exp Ther; 2006 Feb; 316(2):608-17. PubMed ID: 16214880
[TBL] [Abstract][Full Text] [Related]
14. Endocannabinoids contribute to metabotropic glutamate receptor-mediated inhibition of GABA release onto hippocampal CA3 pyramidal neurons in an isolated neuron/bouton preparation.
Inada H; Maejima T; Nakahata Y; Yamaguchi J; Nabekura J; Ishibashi H
Neuroscience; 2010 Feb; 165(4):1377-89. PubMed ID: 19961906
[TBL] [Abstract][Full Text] [Related]
15. Cholinergic modulation of primary afferent glutamatergic transmission in rat medullary dorsal horn neurons.
Jeong SG; Choi IS; Cho JH; Jang IS
Neuropharmacology; 2013 Dec; 75():295-303. PubMed ID: 23954675
[TBL] [Abstract][Full Text] [Related]
16. Role of cannabinoid CB1 receptors and Gi/o protein activation in the modulation of synaptosomal Na+,K+-ATPase activity by WIN55,212-2 and delta(9)-THC.
Araya KA; David Pessoa Mahana C; González LG
Eur J Pharmacol; 2007 Oct; 572(1):32-9. PubMed ID: 17644088
[TBL] [Abstract][Full Text] [Related]
17. Serotonergic modulation of neurotransmission in the rat basolateral amygdala.
Rainnie DG
J Neurophysiol; 1999 Jul; 82(1):69-85. PubMed ID: 10400936
[TBL] [Abstract][Full Text] [Related]
18. Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus.
Laaris N; Good CH; Lupica CR
Neuropharmacology; 2010; 59(1-2):121-7. PubMed ID: 20417220
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoids inhibit striatonigral GABAergic neurotransmission in the mouse.
Wallmichrath I; Szabo B
Neuroscience; 2002; 113(3):671-82. PubMed ID: 12150787
[TBL] [Abstract][Full Text] [Related]
20. Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones.
Straiker A; Mackie K
J Physiol; 2005 Dec; 569(Pt 2):501-17. PubMed ID: 16179366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
